Infectious complications of a rituximab-based immunosuppressive regimen in patients with glomerular disease

BACKGROUND: Recent years have seen increasing use of rituximab (RTX) for various types of primary and secondary glomerulopathies. However, there are no studies that specifically address the risk of infection related to this agent in patients with these conditions. METHODS: We reviewed the outcomes o...

Descripción completa

Detalles Bibliográficos
Autores principales: Trivin, Claire, Tran, Antoine, Moulin, Bruno, Choukroun, Gabriel, Gatault, Philippe, Courivaud, Cécile, Augusto, Jean-François, Ficheux, Maxence, Vigneau, Cécile, Thervet, Eric, Karras, Alexandre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Rituximab
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570029/
https://www.ncbi.nlm.nih.gov/pubmed/28852482
http://dx.doi.org/10.1093/ckj/sfw101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570029/
https://www.ncbi.nlm.nih.gov/pubmed/28852482
http://dx.doi.org/10.1093/ckj/sfw101

Ejemplares similares